Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects

Background Selonsertib is a first-in-class inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with therapeutic potential for fibrotic diseases. This phase I study evaluated the safety, tolerability, pharmacokinetics (PK), and food effect of selonsertib in healthy subjects. Methods This was a d...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical pharmacokinetics Vol. 59; no. 9; pp. 1109 - 1117
Main Authors:	Nelson, Cara H., Etchevers, Kim, Yi, Saili, Breckenridge, David, Hepner, Mischa, Patel, Uptal, Ling, John, Mathias, Anita
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01.09.2020 Springer Nature B.V
Subjects:	Apoptosis Chemokines Drug dosages Food Inflammation Internal Medicine Kinases Laboratories Ligands Medicine Medicine & Public Health Original Research Article Oxidative stress Pharmacodynamics Pharmacokinetics Pharmacology/Toxicology Pharmacotherapy Phosphorylation Urine United States > US
ISSN:	0312-5963, 1179-1926, 1179-1926
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!